Staphylococcus aureus Bacteremia Mortality
A new study reveals that mortality rates for Staphylococcus aureus bacteremia increased significantly between 2019 and 2021, particularly among hospital-onset cases. Researchers found that recent SARS-CoV-2 infection was an independent risk factor that substantially raised the hazard of death.
Why it matters
This research highlights the long-term and secondary impacts of the COVID-19 pandemic on hospital patient outcomes and infection management.
STAPHYLOCOCCUS aureus bacteremia mortality rose during the COVID-19 pandemic, particularly among hospital-onset cases with recent infection.
A population-based analysis of 20 U.S. counties found that 30-day mortality increased substantially in several bacteremia groups from 2019 through 2021. Recent SARS-CoV-2 infection was also independently associated with a markedly higher hazard of death.
Researchers analyzed active laboratory and population surveillance data collected across seven states between 2005 and 2022. The analysis included adults with methicillin-resistant S. aureus (MRSA) or methicillin-susceptible S. aureus (MSSA) bacteremia.
Cases were classified as hospital-onset, healthcare-associated community-onset, or community-associated. Medical records were linked with state vital statistics to identify deaths within 30 days of the incident culture.
Overall, mortality among people with S. aureus bacteremia was 21%. Annual mortality rates were generally stable before the pandemic but increased considerably in selected groups between 2019 and 2021.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in